R-2-hydroxyglutarate (R-2HG), a product of mutated isocitrate dehydrogenase 1/2 (IDH1/2), plays an anti-tumor role in leukemia by inhibiting cell proliferation, promoting cell cycle arrest, and apoptosis (Su et al., 2018). This evidence concerns the gene IDH1 and leukemia.